Literature DB >> 4083867

Cerebrospinal fluid penetration of moxalactam in ventriculostomy patients.

R J Creger, R I Cowan, H S Nearman, J L Blumer, W R Selman, L H Danziger.   

Abstract

The cerebrospinal fluid penetration of moxalactam was simultaneously investigated in three patients with presumed bacterial meningitis. When ratios of simultaneously drawn ventriculostomy to serum moxalactam levels of 1, 2, 3, and 4 h were examined, the penetration ratios were 7.8 +/- 2.4, 11.2 +/- 1.3, 14.2 +/- 2.5, and 15.0 +/- 4.9%, respectively. These ratios were not statistically different from the penetration of moxalactam calculated by the area under the concentration-time curve technique (8.97 +/- 1.89%).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4083867      PMCID: PMC180342          DOI: 10.1128/AAC.28.6.839

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Non-traumatic gram-negative bacillary meningitis in the Detroit Medical Center, 1964-1974; (with special mention of cases due to Escherichia coli).

Authors:  L R Crane; A M Lerner
Journal:  Medicine (Baltimore)       Date:  1978-05       Impact factor: 1.889

2.  Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.

Authors:  R Lüthy; J Blaser; A Bonetti; H Simmen; R Wise; W Siegenthaler
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

3.  Diffusion of moxalactam into the cerebrospinal fluid in children with bacterial meningitis.

Authors:  M C Thirumoorthi; J A Buckley; M K Aravind; R E Kauffman; A S Dajani
Journal:  J Pediatr       Date:  1981-12       Impact factor: 4.406

Review 4.  Pharmacokinetics of tissue penetration of antibiotics.

Authors:  T Bergan
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

5.  Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.

Authors:  U B Schaad; G H McCracken; C A Loock; M L Thomas
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

Review 6.  Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis.

Authors:  S H Landesman; M L Corrado; P M Shah; M Armengaud; M Barza; C E Cherubin
Journal:  Am J Med       Date:  1981-10       Impact factor: 4.965

7.  Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis.

Authors:  S L Kaplan; E O Mason; H Garcia; S J Kvernland; E M Loiselle; D C Anderson; A A Mintz; R D Feigin
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

8.  Sequential ventricular fluid concentrations of ceftazidime--report of three cases.

Authors:  R E Polk; C G Mayhall; T Tartaglione; J Baggett; P Patterson
Journal:  Drug Intell Clin Pharm       Date:  1984-12

9.  Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.

Authors:  U B Schaad; G H McCracken; N Threlkeld; M L Thomas
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

10.  Successful treatment of gram-negative bacillary meningitis with moxalactam.

Authors:  D A Olson; P D Hoeprich; S M Nolan; E Goldstein
Journal:  Ann Intern Med       Date:  1981-09       Impact factor: 25.391

View more
  1 in total

1.  Penetration of cefuroxime into ventricular fluid in cerebrospinal fluid shunt infections.

Authors:  M S Edwards; C J Baker; K M Butler; E O Mason; J P Laurent; W R Cheek
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.